<div id="readability-page-1"><p>In a report released today, Travis Steed from Bank of America Securities reiterated a Hold rating on Haemonetics, with a price target of <span id="expert-recommendation-target">$90.00</span>.</p><h3>TipRanks Cyber Monday Sale</h3><ul><li> Claim 60% off TipRanks Premium  for data-backed insights and research tools you need to invest with confidence.  </li><li>  Subscribe to TipRanks' Smart Investor Picks  and see our data in action through our high-performing model portfolio - <u> now also 60% off </u></li></ul> <p>Steed covers the Healthcare sector, focusing on stocks such as Boston Scientific, Intuitive Surgical, and Penumbra. According to TipRanks, Steed has an average return of <span>8.3%</span> and a 61.73% success rate on recommended stocks. </p> <p>Haemonetics has an analyst consensus of Strong Buy, with a price target consensus of $81.00.</p></div>

<p>Bank of America Securities analyst Travis Steed reiterated a Hold rating on Haemonetics with a $90 price target. Despite a Strong Buy consensus among analysts, the consensus price target is $81. Steed, who covers the Healthcare sector, has an average return of 8.3% and a 61.73% success rate on stock recommendations.</p>

Haemonetics (HAE) Gets a Hold from Bank of America Securities